These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 17378367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Circulation; 2005 Jun 28; 111(25):3429-34. PubMed ID: 15956122
    [Abstract] [Full Text] [Related]

  • 3. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Am J Hypertens; 2005 Nov 28; 18(11):1508-16. PubMed ID: 16280290
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
    Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Am J Hypertens; 2006 Oct 28; 19(10):1084-91. PubMed ID: 17027833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study.
    Ukkola O, Rankinen T, Weisnagel SJ, Sun G, Pérusse L, Chagnon YC, Després JP, Bouchard C.
    Metabolism; 2000 Aug 28; 49(8):1063-70. PubMed ID: 10954027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lys418Asn polymorphism of the alpha2-adrenoceptor gene relates to serum uric acid levels but not to insulin sensitivity.
    Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Hypertension; 2005 Jul 28; 46(1):144-50. PubMed ID: 15939803
    [Abstract] [Full Text] [Related]

  • 12. Circulating ghrelin levels in obese women: a possible association with hypertension.
    Oner-Iyidoğan Y, Koçak H, Gürdöl F, Oner P, Issever H, Esin D.
    Scand J Clin Lab Invest; 2007 Jul 28; 67(5):568-76. PubMed ID: 17763194
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.
    Daghestani M, Daghestani M, Daghistani M, Eldali A, Hassan ZK, Elamin MH, Warsy A.
    Lipids Health Dis; 2018 Mar 27; 17(1):58. PubMed ID: 29587766
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain.
    Koda M, Ando F, Niino N, Shimokata H, Miyasaka K, Funakoshi A.
    Obes Res; 2004 Aug 27; 12(8):1212-6. PubMed ID: 15340101
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.